Stock splits are typically viewed as bullish indicators that a company sees more growth is on the horizon. Although nothing ...

DNA testing company 23andMe is in financial crisis, raising questions about what will happen to the data it holds on 15 milli ...

Me helped usher in the era of consumer DNA test kits nearly two decades ago, but has more recently faced a series of setbacks ...

The company’s valuation had dropped from $6 billion in 2021, to under $150 million after going public and when CEO Anne Wojcicki pushed for a plan to buy it and take it private, the board rejected her ...